Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Publications

Objectives

The aim of this study was to compare the prevalence of Q Fever infection at herd level between farms reporting abortions and those reporting only other reproductive disorders.

  • Abortions / premature delivery / stillbirth / weak born offspring (APSW complex).
  • Metritis / endometritis.
  • Retained placenta.
  • Infertility.

Materials and Methods

PCR testing of bulk tank milk (BTM) is a simple and affordable way of testing for the presence of Coxiella burnetii in dairy herds. In 2020, Ceva and Qualyse developed QTest to facilitate the collection and transport of samples to the laboratory.  QTest combines an easy sampling medium (FTA® card) that inactivates micro-organisms while preserving nucleic acids, with real-time PCR analysis carried out in a single laboratory in France. The use of QTest increases the sensitivity of BTM analyses (Treilles et al., 2021). Each QTest is accompanied by a sample identification form. On this form, the breeder or veterinarian sending the sample indicates any reproductive disorders present on the farm. It is possible to tick several boxes: The objective of QTest is to identify the presence of Coxiella burnetii in herds exhibiting reproductive dysfunction. In the present study, the results obtained over a four-year period, from October 2020 to September 2024, were subjected to analysis. The herds were classified into two groups. The first group comprised herds that had reported the APSW complex,
while the second group consisted of herds that had reported any of the other reproductive disorders. As multiple clinical signs could be reported, it was decided to assign to the APSW complex group, herds where both APSW complex and at least one other clinical sign were reported. The results of the two groups were then compared using the chi-square test.

Results

During the study period 2014 samples were collected from farms where at least one reproductive disorder had been reported. The geographical origin is shown in Figure 1.

APSW complex was reported on 1261 farms (62.6%). The presence of Coxiella burnetii in BTM was detected in 44.0% of them (n = 555). 753 farms (37.4%) reported only other reproductive disorders. Of these, 40.4% were positive for Coxiella burnetii in BTM (n = 304). The difference in prevalence was not statistically different between the two categories (p=0.11, Chi-square test)
(Table 1).

Conclusions

These results suggest that the presence of Coxiella burnetii in dairy cattle can be associated without difference with major reproductive disorders (abortions, premature delivery, stillbirth, weak born calves) or other reproductive disorders (metritis/endometritis, retained placenta, infertility). Testing for Coxiella burnetii should therefore be considered in herds with reproductive
problems, even in the absence of a high abortion rate.

Share this publication:

Publication file:

Download publication
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.